These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37662880)

  • 21. Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use.
    Dahlgren J; Veimo D; Johansson L; Bech I
    Curr Med Res Opin; 2007 Jul; 23(7):1649-55. PubMed ID: 17559757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Driving Patient Preferences for Growth Hormone Deficiency (GHD) Injection Regimen and Injection Device Features: A Discrete Choice Experiment.
    McNamara M; Turner-Bowker DM; Westhead H; Yaworsky A; Palladino A; Gross H; Pleil A; Loftus J
    Patient Prefer Adherence; 2020; 14():781-793. PubMed ID: 32431492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of Adherence Monitoring in Adult Patients With Growth Hormone Deficiency Under Replacement Therapy: Preliminary Monocentric Data With Easypod
    Mancini A; Vergani E; Bruno C; Palladino A; Brunetti A
    Front Endocrinol (Lausanne); 2019; 10():416. PubMed ID: 31316468
    [No Abstract]   [Full Text] [Related]  

  • 24. Recombinant growth hormone in children and adolescents with Turner syndrome.
    Cave CB; Bryant J; Milne R
    Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digital technologies to improve the precision of paediatric growth disorder diagnosis and management.
    Dunkel L; Fernandez-Luque L; Loche S; Savage MO
    Growth Horm IGF Res; 2021 Aug; 59():101408. PubMed ID: 34102547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Observed High Adherence to Recombinant Human Growth Hormone Treatment Using a Multi-Component Approach to Improve Adherence in Individuals with Growth Disorders.
    Morgan K; Van Dommelen P; Batista AR; Koledova E
    Stud Health Technol Inform; 2022 May; 294():817-818. PubMed ID: 35612215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial.
    Czepielewski MA; Garret Q; Vencio SAC; Rassi N; Felicio JS; Faria MS; Senn CCP; Bronstein MD; Cerqueira MJAG; Neves ACL; Sgarbi JA; Spinola-Castro AM; Cunha MPR; Bandeira F; Toffoletto O; Afiune J; Baradelli R; Rodrigues DG; Scharf M
    Growth Horm IGF Res; 2019; 48-49():29-35. PubMed ID: 31493626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous Interferon β-1a Administration by Electronic Auto-injector is Associated with High Adherence in Patients with Relapsing Remitting Multiple Sclerosis in a Real-life Study.
    Järvinen E; Multanen J; Atula S
    Neurol Int; 2017 Feb; 9(1):6957. PubMed ID: 28286627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults.
    Turner-Bowker DM; Yaworsky A; Palladino A; Lamoureux RE; Kelly M; Love E; Pleil AM; Shields A; Loftus J
    Patient; 2020 Jun; 13(3):289-306. PubMed ID: 31956960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimum method for administration of biosynthetic human growth hormone: a randomised crossover trial of an Auto Injector and a pen injection system.
    Stanhope R; Albanese A; Moyle L; Hamill G
    Arch Dis Child; 1992 Aug; 67(8):994-7. PubMed ID: 1520018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment Adherence to Injectable Treatments in Pediatric Growth Hormone Deficiency Compared With Injectable Treatments in Other Chronic Pediatric Conditions: A Systematic Literature Review.
    Gomez R; Ahmed SF; Maghnie M; Li D; Tanaka T; Miller BS
    Front Endocrinol (Lausanne); 2022; 13():795224. PubMed ID: 35299969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency.
    Johannsson G; Nespithal K; Plöckinger U; Alam V; McLean M
    J Endocrinol Invest; 2018 Aug; 41(8):919-927. PubMed ID: 29488103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perception of Adherence to Daily Human Growth Hormone Treatments Among Pediatric and Adolescent Patients in Japan: A Cross-Sectional Survey of Physicians and Caregivers.
    Akazawa M; Shima D; Sato T; Shoji E; LoPresti M; Nishi R
    Patient Prefer Adherence; 2022; 16():3081-3094. PubMed ID: 36387049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the Usefulness and Ease of Use of a Next-Generation-Connected Drug Delivery Device for Growth Hormone Therapy: Qualitative Study of Health Care Professionals' Perceptions.
    Labarta JI; Dimitri P; Keiser M; Koledova E; Rivera-Romero O
    JMIR Hum Factors; 2023 Aug; 10():e46893. PubMed ID: 37531173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring Potentially Modifiable Factors That Influence Treatment Non-Adherence Amongst Pediatric Growth Hormone Deficiency: A Qualitative Study.
    Graham S; Auyeung V; Weinman J
    Patient Prefer Adherence; 2020; 14():1889-1899. PubMed ID: 33116433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptability of Liquid Human Growth Hormone (hGH) [Norditropin Simple Xx®] in Adults and Children with GH Deficiency and Children with Chronic Renal Disease.
    Drent ML; Jakobsdottir S; van Wijk JAE; Oostdijk W; Wit JM
    Clin Drug Investig; 2002 Sep; 22(9):633-638. PubMed ID: 29492857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Daily Growth Hormone Injection Adherence and Height Among Children With Growth Hormone Deficiency.
    Loftus J; Miller BS; Parzynski CS; Alvir J; Chen Y; Jhingran P; Gupta A; DeKoven M; Divino V; Tse J; He J; Wajnrajch M
    Endocr Pract; 2022 Jun; 28(6):565-571. PubMed ID: 35263660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying Potentially Modifiable Factors Associated with Treatment Non-Adherence in Paediatric Growth Hormone Deficiency: A Systematic Review.
    Graham S; Weinman J; Auyeung V
    Horm Res Paediatr; 2018; 90(4):221-227. PubMed ID: 30522126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring of treatment adherence with easypod™ in six Italian centers: a real-world experience.
    Cardinale GM; Pesce S; Ingletto D; Mariano M; Catucci A; Corciulo N; Fidotti E
    Minerva Endocrinol; 2019 Sep; 44(3):246-251. PubMed ID: 30482007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to somatotropin treatment administered with an electronic device.
    Arrabal Vela MA; García Gijón CP; Pascual Martin M; Benet Giménez I; Áreas Del Águila V; Muñoz-Rodríguez JR; Palomo Atance E
    Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(6):314-318. PubMed ID: 29680781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.